BiomeSense won University of Chicago Innovation Fund's competition for its proposed biosensor that could provide medical feedback based on the bacteria found in a patient's faeces.
BiomeSense, a US-based biosensor developer spun out from University of Chicago, secured up to $250,000 on Wednesday from the university’s Innovation Fund.
BiomeSense is developing biosensor technology that improves the feedback gained from clinical therapies by evaluating the bacteria in a patient’s faeces. The system works through a toilet accessory installed in the patient’s home, sending sampled data to a cloud-based platform for monitoring by clinicians.
The spinout will initially target researchers who could deploy the device in clinical trial…
